Pelvic inflammatory disease laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}};{{AE}}{{MehdiP}}
{{CMG}};{{AE}}{{MehdiP}}
==Overview==
==Overview==
There is no specific laboratory findings for PID. Elevated [[ESR]] and [[CRP]] are suggestive for diagnosis but are not specific. NAAT for N. gonorrhoeae and C. trachomatis must be requested.
There is no specific laboratory findings for PID. Elevated [[ESR]] and [[CRP]] are suggestive for diagnosis but are not specific. [[Nucleic acid test|NAAT]] for [[Neisseria gonorrhoeae|N. gonorrhoeae]] and [[Chlamydia trachomatis|C. trachomatis]] must be requested.
==Laboratory findings==
==Laboratory findings==
*There is no specific laboratory findings for PID. Elevated [[CRP]] and [[ESR]] are non specific findings. [[Leukocytosis]] is another findings.
*There is no specific laboratory findings for PID. Elevated [[CRP]] and [[ESR]] are non specific findings. [[Leukocytosis]] is another findings.
*Laboratory confirmation of [[Chlamydia]], [[Gonorrhea]] and/or [[Mycoplasma genitalium]] in cervical discharge is helpful to guide treatment.<ref name="pmid26042815">{{cite journal |vauthors=Workowski KA, Bolan GA |title=Sexually transmitted diseases treatment guidelines, 2015 |journal=MMWR Recomm Rep |volume=64 |issue=RR-03 |pages=1–137 |year=2015 |pmid=26042815 |doi= |url=}}</ref>
*Laboratory confirmation of [[Chlamydia]], [[Gonorrhea]] and/or [[Mycoplasma genitalium]] in cervical discharge is helpful to guide treatment.<ref name="pmid26042815">{{cite journal |vauthors=Workowski KA, Bolan GA |title=Sexually transmitted diseases treatment guidelines, 2015 |journal=MMWR Recomm Rep |volume=64 |issue=RR-03 |pages=1–137 |year=2015 |pmid=26042815 |doi= |url=}}</ref>
*All patients with suspected pelvic inflammatory disease should undergo cervical or vaginal nucleic acid amplification tests for [[N. gonorrhoeae]] and [[Chlamydia trachomatis|C. trachomatis]] infection.<ref name="pmid25992748">{{cite journal |vauthors=Brunham RC, Gottlieb SL, Paavonen J |title=Pelvic inflammatory disease |journal=N. Engl. J. Med. |volume=372 |issue=21 |pages=2039–48 |year=2015 |pmid=25992748 |doi=10.1056/NEJMra1411426 |url=}}</ref>
*All patients with suspected pelvic inflammatory disease should undergo cervical or vaginal [[Nucleic acid amplification technique|nucleic acid amplification tests]] for [[N. gonorrhoeae]] and [[Chlamydia trachomatis|C. trachomatis]] infection.<ref name="pmid25992748">{{cite journal |vauthors=Brunham RC, Gottlieb SL, Paavonen J |title=Pelvic inflammatory disease |journal=N. Engl. J. Med. |volume=372 |issue=21 |pages=2039–48 |year=2015 |pmid=25992748 |doi=10.1056/NEJMra1411426 |url=}}</ref>
*Vaginal fluid should be evaluated for increased numbers of [[White blood cells|white cells]] (more than one [[neutrophil]] per [[Epithelial cells|epithelial cell]]) and signs of [[bacterial vaginosis]].<ref name="pmid25992748">{{cite journal |vauthors=Brunham RC, Gottlieb SL, Paavonen J |title=Pelvic inflammatory disease |journal=N. Engl. J. Med. |volume=372 |issue=21 |pages=2039–48 |year=2015 |pmid=25992748 |doi=10.1056/NEJMra1411426 |url=}}</ref>
*Vaginal fluid should be evaluated for increased numbers of [[White blood cells|white cells]] (more than one [[neutrophil]] per [[Epithelial cells|epithelial cell]]) and signs of [[bacterial vaginosis]].<ref name="pmid25992748">{{cite journal |vauthors=Brunham RC, Gottlieb SL, Paavonen J |title=Pelvic inflammatory disease |journal=N. Engl. J. Med. |volume=372 |issue=21 |pages=2039–48 |year=2015 |pmid=25992748 |doi=10.1056/NEJMra1411426 |url=}}</ref>
*Pregnancy test should be routinely requested to help rule out [[ectopic pregnancy]].
*Pregnancy test should be routinely requested to help rule out [[ectopic pregnancy]].

Revision as of 14:29, 21 October 2016

Pelvic inflammatory disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pelvic Inflammatory Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pelvic inflammatory disease laboratory findings On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pelvic inflammatory disease laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pelvic inflammatory disease laboratory findings

CDC on Pelvic inflammatory disease laboratory findings

Pelvic inflammatory disease laboratory findings in the news

Blogs on Pelvic inflammatory disease laboratory findings

to Hospitals Treating Pelvic inflammatory disease

Risk calculators and risk factors for Pelvic inflammatory disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

There is no specific laboratory findings for PID. Elevated ESR and CRP are suggestive for diagnosis but are not specific. NAAT for N. gonorrhoeae and C. trachomatis must be requested.

Laboratory findings

References

  1. Workowski KA, Bolan GA (2015). "Sexually transmitted diseases treatment guidelines, 2015". MMWR Recomm Rep. 64 (RR-03): 1–137. PMID 26042815.
  2. 2.0 2.1 2.2 Brunham RC, Gottlieb SL, Paavonen J (2015). "Pelvic inflammatory disease". N. Engl. J. Med. 372 (21): 2039–48. doi:10.1056/NEJMra1411426. PMID 25992748.

Template:WH Template:WS